NOTIFICATION NO. 08/2021, DT. 14/06/2021

S.O. (E) In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No . 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby amends the Notification No. 01/ 2015-20 dated 11.04.2021 related to export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API):
 

2. The export of Remdesivir Injections/ API against the Advance Authorizati ons issued under Chapter 4 of FTP/ HBP shall not require a separate export authorisation or permission.

3. Effect of this Notification:

The export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) falling under the ITC (HS) Codes specified above or falling under any other HS Code has been put under Restricted category with immediate effect. The export of Remdesivir Injections/ API against the Advance Authorizations will not require a separate authorisation/ permission.
 

(Amit Yadav)

Director General of Foreign Trade
Ex-Officio Additional Secretary, GoI
Email- dgft@nic.in

(Issued from F.No.01/91/180/24/AM22/EC/E-27724)